Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005783 | endoplasmic reticulum | 5 | 3 |
GO:0005794 | Golgi apparatus | 5 | 3 |
GO:0016020 | membrane | 2 | 17 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 17 |
Related structures:
AlphaFold database: Q4QGX1
Term | Name | Level | Count |
---|---|---|---|
GO:0006497 | protein lipidation | 5 | 3 |
GO:0006605 | protein targeting | 5 | 3 |
GO:0006612 | protein targeting to membrane | 5 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0006810 | transport | 3 | 3 |
GO:0006886 | intracellular protein transport | 4 | 3 |
GO:0006897 | endocytosis | 5 | 3 |
GO:0008104 | protein localization | 4 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0015031 | protein transport | 4 | 3 |
GO:0016192 | vesicle-mediated transport | 4 | 3 |
GO:0018193 | peptidyl-amino acid modification | 5 | 3 |
GO:0018198 | peptidyl-cysteine modification | 6 | 3 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 7 | 3 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 7 | 3 |
GO:0018345 | protein palmitoylation | 6 | 3 |
GO:0019538 | protein metabolic process | 3 | 3 |
GO:0033036 | macromolecule localization | 2 | 3 |
GO:0036211 | protein modification process | 4 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0043412 | macromolecule modification | 4 | 3 |
GO:0043543 | protein acylation | 5 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0045184 | establishment of protein localization | 3 | 3 |
GO:0046907 | intracellular transport | 3 | 3 |
GO:0051179 | localization | 1 | 3 |
GO:0051234 | establishment of localization | 2 | 3 |
GO:0051641 | cellular localization | 2 | 3 |
GO:0051649 | establishment of localization in cell | 3 | 3 |
GO:0051668 | localization within membrane | 3 | 3 |
GO:0070727 | cellular macromolecule localization | 3 | 3 |
GO:0071702 | organic substance transport | 4 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:0071705 | nitrogen compound transport | 4 | 3 |
GO:0072657 | protein localization to membrane | 4 | 3 |
GO:0090150 | establishment of protein localization to membrane | 4 | 3 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 17 |
GO:0016409 | palmitoyltransferase activity | 5 | 17 |
GO:0016417 | S-acyltransferase activity | 5 | 17 |
GO:0016740 | transferase activity | 2 | 17 |
GO:0016746 | acyltransferase activity | 3 | 17 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 17 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 4 | 17 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 3 | 17 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 17 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 171 | 175 | PF00656 | 0.511 |
CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.270 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.423 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.299 |
CLV_PCSK_FUR_1 | 77 | 81 | PF00082 | 0.347 |
CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.259 |
CLV_PCSK_KEX2_1 | 287 | 289 | PF00082 | 0.327 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.423 |
CLV_PCSK_KEX2_1 | 79 | 81 | PF00082 | 0.299 |
CLV_PCSK_PC1ET2_1 | 287 | 289 | PF00082 | 0.330 |
CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.349 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.568 |
DOC_MAPK_MEF2A_6 | 245 | 253 | PF00069 | 0.419 |
DOC_PP2B_LxvP_1 | 24 | 27 | PF13499 | 0.592 |
DOC_PP4_FxxP_1 | 292 | 295 | PF00568 | 0.532 |
DOC_PP4_FxxP_1 | 83 | 86 | PF00568 | 0.496 |
DOC_USP7_MATH_1 | 221 | 225 | PF00917 | 0.310 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.614 |
DOC_USP7_MATH_1 | 58 | 62 | PF00917 | 0.629 |
DOC_USP7_MATH_1 | 86 | 90 | PF00917 | 0.578 |
DOC_USP7_UBL2_3 | 179 | 183 | PF12436 | 0.451 |
LIG_14-3-3_CanoR_1 | 277 | 282 | PF00244 | 0.433 |
LIG_14-3-3_CanoR_1 | 85 | 91 | PF00244 | 0.498 |
LIG_Actin_WH2_2 | 263 | 279 | PF00022 | 0.403 |
LIG_BIR_III_4 | 31 | 35 | PF00653 | 0.616 |
LIG_BRCT_BRCA1_1 | 106 | 110 | PF00533 | 0.381 |
LIG_BRCT_BRCA1_1 | 240 | 244 | PF00533 | 0.311 |
LIG_FHA_1 | 289 | 295 | PF00498 | 0.646 |
LIG_FHA_2 | 169 | 175 | PF00498 | 0.506 |
LIG_LIR_Apic_2 | 289 | 295 | PF02991 | 0.515 |
LIG_LIR_Gen_1 | 202 | 211 | PF02991 | 0.464 |
LIG_LIR_Gen_1 | 214 | 222 | PF02991 | 0.368 |
LIG_LIR_Gen_1 | 278 | 285 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 107 | 113 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 202 | 207 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 214 | 219 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 278 | 284 | PF02991 | 0.489 |
LIG_MLH1_MIPbox_1 | 240 | 244 | PF16413 | 0.311 |
LIG_PCNA_yPIPBox_3 | 121 | 129 | PF02747 | 0.213 |
LIG_Pex14_1 | 106 | 110 | PF04695 | 0.285 |
LIG_Pex14_2 | 131 | 135 | PF04695 | 0.453 |
LIG_Pex14_2 | 147 | 151 | PF04695 | 0.467 |
LIG_SH2_CRK | 97 | 101 | PF00017 | 0.401 |
LIG_SH2_PTP2 | 113 | 116 | PF00017 | 0.370 |
LIG_SH2_SRC | 281 | 284 | PF00017 | 0.505 |
LIG_SH2_SRC | 90 | 93 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.232 |
LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.227 |
LIG_SH2_STAT5 | 143 | 146 | PF00017 | 0.500 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 243 | 246 | PF00017 | 0.272 |
LIG_SH2_STAT5 | 271 | 274 | PF00017 | 0.475 |
LIG_SH2_STAT5 | 97 | 100 | PF00017 | 0.386 |
LIG_SH3_3 | 20 | 26 | PF00018 | 0.617 |
LIG_TYR_ITSM | 277 | 284 | PF00017 | 0.511 |
LIG_WRC_WIRS_1 | 216 | 221 | PF05994 | 0.246 |
MOD_CK1_1 | 214 | 220 | PF00069 | 0.332 |
MOD_CK1_1 | 301 | 307 | PF00069 | 0.689 |
MOD_CK2_1 | 4 | 10 | PF00069 | 0.677 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.715 |
MOD_Cter_Amidation | 285 | 288 | PF01082 | 0.295 |
MOD_GlcNHglycan | 10 | 14 | PF01048 | 0.436 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.325 |
MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.360 |
MOD_GlcNHglycan | 240 | 243 | PF01048 | 0.570 |
MOD_GSK3_1 | 168 | 175 | PF00069 | 0.486 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.355 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.509 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.545 |
MOD_N-GLC_2 | 182 | 184 | PF02516 | 0.280 |
MOD_N-GLC_2 | 196 | 198 | PF02516 | 0.245 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.300 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.504 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.462 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.701 |
MOD_NEK2_2 | 130 | 135 | PF00069 | 0.459 |
MOD_PIKK_1 | 115 | 121 | PF00454 | 0.386 |
MOD_PKA_1 | 168 | 174 | PF00069 | 0.525 |
MOD_PKA_2 | 168 | 174 | PF00069 | 0.483 |
MOD_PKA_2 | 238 | 244 | PF00069 | 0.206 |
MOD_PKA_2 | 276 | 282 | PF00069 | 0.449 |
MOD_PKA_2 | 73 | 79 | PF00069 | 0.597 |
MOD_Plk_1 | 288 | 294 | PF00069 | 0.532 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.316 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.372 |
MOD_Plk_4 | 211 | 217 | PF00069 | 0.346 |
MOD_Plk_4 | 221 | 227 | PF00069 | 0.472 |
TRG_ENDOCYTIC_2 | 113 | 116 | PF00928 | 0.268 |
TRG_ENDOCYTIC_2 | 143 | 146 | PF00928 | 0.552 |
TRG_ENDOCYTIC_2 | 204 | 207 | PF00928 | 0.451 |
TRG_ENDOCYTIC_2 | 271 | 274 | PF00928 | 0.504 |
TRG_ENDOCYTIC_2 | 281 | 284 | PF00928 | 0.434 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.390 |
TRG_ER_diArg_1 | 168 | 170 | PF00400 | 0.461 |
TRG_ER_diArg_1 | 67 | 69 | PF00400 | 0.603 |
TRG_ER_diArg_1 | 77 | 80 | PF00400 | 0.529 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3T7 | Leptomonas seymouri | 31% | 76% |
A0A0N1I382 | Leptomonas seymouri | 49% | 76% |
A0A1X0NUX2 | Trypanosomatidae | 30% | 84% |
A0A3R7RC91 | Trypanosoma rangeli | 29% | 92% |
A0A3S5H6J6 | Leishmania donovani | 91% | 96% |
A0A3S7WX91 | Leishmania donovani | 29% | 78% |
A4H6N3 | Leishmania braziliensis | 70% | 70% |
A4HCH5 | Leishmania braziliensis | 31% | 77% |
A4HV17 | Leishmania infantum | 90% | 66% |
C9ZSP6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 87% |
E9AH03 | Leishmania infantum | 29% | 78% |
E9AVW7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 78% |
Q4QBL2 | Leishmania major | 30% | 78% |
Q750R7 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 26% | 84% |
V5B8P9 | Trypanosoma cruzi | 32% | 89% |
V5BWI0 | Trypanosoma cruzi | 45% | 90% |